Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
4.640
-0.010 (-0.22%)
Dec 5, 2025, 4:00 PM EST - Market closed
Genelux Market Cap
Genelux has a market cap or net worth of $174.55 million as of December 5, 2025. Its market cap has increased by 106.37% in one year.
Market Cap
174.55M
Enterprise Value
155.26M
1-Year Change
106.37%
Ranking
Category
Stock Price
$4.64
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has increased from $141.69M to $174.55M, an increase of 23.19%. That is a compound annual growth rate of 7.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 174.55M | 116.87% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |